Sentences with phrase «by pharmaceutical interests»
Blue Man - The story of Paul Karason - a mass media deception orchastrated by pharmaceutical interests to scare the public away from using colloidal silver products.
http://www.silver-colloids.com/ Not exact matches
Advocates for kratom tend to argue that the FDA is protecting big pharmaceutical interests — or at the very least isn't keeping an open mind — by cracking down on the product.
In a sign of renewed interest in Baltimore's downtown business district, more companies are looking to boost their visibility by splashing names and logos atop prominent Inner Harbor office towers.In recent months, R2integrated, Lupin Pharmaceuticals...
The powerful lobbying organisation, which receives funding from pharmaceutical, weapons and oil interests among others, is heavily funded by the Koch Charitable Foundation whose founder, Charles G Koch, is one of the most generous donors to the Tea Party movement in the US.
The list of top donors to housekeeping accounts is dominated by special interests that are highly regulated and / or subsidized by state government: real estate firms, health - care and pharmaceutical interests, labor unions, telecom companies, the beverage industry, big tobacco and gambling interests.
The untold millions of mice, rats, and even dogs owned by pharmaceutical companies, biotech corporations, and other industry labs are off the table says Bellotti, noting the business interests of his more conservative allies.
Motivated by the interests of a pharmaceutical industry unlikely to profit from the treatments, Audley says, the society wants to «change the laws in all civilized countries to outlaw these therapies».
They also complain that a 2004 WHO pandemic - preparedness document did not reveal that some of its authors had been paid for work by pharmaceutical companies — although the scientists had declared their competing interests elsewhere.
Jagadeesh et al. report a class of nonprecious cobalt nanoparticles that catalyze this reaction across a very broad range of substrates, including complex molecules of pharmaceutical interest (see the Perspective by Chen and Xu).
By following her expanding interests, she navigated through the pharmaceutical R&D sector until she reached her current position as head of regulatory affairs at the biotech company Centocor.
The growing restrictions drove the older industries in the chemical, petroleum and pharmaceutical fields to protect their business interests by opposing new regulations.
This form of interference with bacterial gene regulation is also of pharmaceutical interest as it is known that pathogenic bacteria can protect themselves against attack by the immune system and the effect of antibiotics by forming biofilms, for instance on the epithelium of the respiratory system.
«The ability to control the functional states of opioid receptors is of particular interest because they belong to the large family of so - called G - protein - coupled transmembrane receptors (GPCRs), which make up a large fraction of the proteins targeted by pharmaceutical agents,» says Matthias Schönberger, first author of the new study.
Adjoining properties have been reserved by the County for the Palm Beach County Research Village, future home of biotech and pharmaceutical organizations, commercial interests, and residences.
The chemical reactions she has developed are widely used throughout the pharmaceutical industry to create new drug candidates, are being studied by chemical companies interested in accessing important chemicals used in farming, and are being utilized to prepare a type of chemical (tracer) that allows doctors to view the heart's sympathetic nervous system through positron emission tomography (PET) scans.
Problems are primarily motivated by health care technologies of interest to pharmaceutical and biotechnological companies, and emphasize multi-disciplinary collaborative interactions, including colleagues in both academia and industry.
But fueled by bias, vested interests, and institutional momentum, the complete lack of evidence has not stopped the media, health organizations, or pharmaceutical companies from continuing to tout their favored — albeit faulty — hypothesis as fact.
MK - 2866 was created and researched by pharmaceutical industry due to increasing medical interest in SARMs.
However, most of these claims are based on studies funded by pharmaceutical companies with a vested interest in promoting the use of their products.
Equally bothersome, many patients — swayed by media advertisements from pharmaceutical companies and healthcare plans pushing their products and procedures — suddenly had little interest in lifestyle changes.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.
APEP, in other words, is an institution that acknowledges that interests play an inevitable role in the evaluation of pharmaceutical research, and it ensures that the interests of pharmaceutical companies are not allowed free - reign but rather are checked by interests that are diametrically opposed to them.
If you have been harmed by the negligence of a pharmaceutical company, it's in your best interest to contact a Boston drug injury lawyer today.
At our nationwide defective drug practice, we aim to assist those adversely affected by dangerous medications such as Lipitor, and we continuously monitor developments taking place within the pharmaceutical industry to better understand products and protect our clients» interests.
One of the interesting submissions is by PhRMA (@FDASM) which is requesting a prominent universal symbol placed on all pharmaceutical company generated content.
He describes a lecture that he gave to about two thousand members of the American Medical Association during which he asked the physicians whether they felt that their medical judgments were affected by conflicts of interests with their hospital, drug manufacturers, insurance companies, medical device manufacturers or pharmaceutical sales representatives.
I am highly interested in obtaining a Biology Intern position at Takeda Pharmaceuticals — I have recently discovered that you are actively looking for interns, and I am positive that by hiring me, part of your requirements will be fulfilled.
On the cost efficiency — or not — of our health system, an interesting article by Australian researchers was published by The Conversation explaining the concept of patent «evergreening» — a strategy pharmaceutical companies use to keep the cost of medicines (and their profits) high.
APA requires authors to reveal any possible conflict of interest in the conduct and reporting of research (e.g., financial interests in a test or procedure, funding by pharmaceutical companies for drug research).